Literature DB >> 18957871

Implantation of dedifferentiated fat cells ameliorates habu snake venom-induced chronic renal dysfunction in tenascin-C-deficient mice.

Renaguli Nur1, Noboru Fukuda, Taro Matsumoto, Jumabay Medet, Koichiro Kano, Chii Yamamoto, Takashi Maruyama, Morito Endo, Koichi Matsumoto.   

Abstract

BACKGROUND/AIMS: We established dedifferentiated fat (DFAT) cells from mature adipocytes that differentiate to multiple lineages and have characteristics similar to those of mesenchymal stem cells. In this study, we evaluated the effect of implantation of DFAT cells on habu snake venom (HSV)-induced renal dysfunction in tenascin-C knockout (TC-KO) mice.
METHODS: Cultured DFAT cells were incubated with PDGF-BB and immunostained with anti-desmin antibody to determine mesenchymal differentiation. HSV was injected, and DFAT cells from GFP mice were implanted in TC-KO mice via the tail vein. Expression of tenascin-C, transforming growth factor-beta(1) (TGF-beta1), and fibronectin mRNAs in the renal cortex were evaluated by RT-PCR analysis.
RESULTS: Cultured DFAT cells showed desmin immunostaining in response to PDGF-BB.HSV injection induced glomerulosclerosis, which was significantly improved by implantation of DFAT cells. Serum BUN increased after HSV injection and was significantly decreased by implantation of DFAT cells. Tenascin-C mRNA was detected in the renal cortex in implanted mice. Expression of TGF-beta1 and fibronectin mRNAs increased in the renal cortex after HSV injection, and was significantly decreased by implantation of DFAT cells.
CONCLUSION: DFAT cells may provide a source for cell therapy for severe progressive renal disease. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18957871     DOI: 10.1159/000166995

Source DB:  PubMed          Journal:  Nephron Exp Nephrol        ISSN: 1660-2129


  7 in total

1.  Spontaneously beating cardiomyocytes derived from white mature adipocytes.

Authors:  Medet Jumabay; Rui Zhang; Yucheng Yao; Joshua I Goldhaber; Kristina I Boström
Journal:  Cardiovasc Res       Date:  2010-01-01       Impact factor: 10.787

2.  Corrigendum to "Dedifferentiated fat cells in polyglycolic acid-collagen nerve conduits promote rat facial nerve regeneration" [Regen Ther 11 (2019) 240-248].

Authors:  Hiroshi Fujimaki; Hajime Matsumine; Hironobu Osaki; Yoshifumi Ueta; Wataru Kamei; Mari Shimizu; Kazuki Hashimoto; Kaori Fujii; Tomohiko Kazama; Taro Matsumoto; Yosuke Niimi; Mariko Miyata; Hiroyuki Sakurai
Journal:  Regen Ther       Date:  2020-06-10       Impact factor: 3.419

Review 3.  Cell-based therapies for experimental chronic kidney disease: a systematic review and meta-analysis.

Authors:  Diana A Papazova; Nynke R Oosterhuis; Hendrik Gremmels; Arianne van Koppen; Jaap A Joles; Marianne C Verhaar
Journal:  Dis Model Mech       Date:  2015-01-29       Impact factor: 5.758

4.  Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6.

Authors:  Takashi Maruyama; Noboru Fukuda; Taro Matsumoto; Koichiro Kano; Morito Endo; Minako Kazama; Tomohiko Kazama; Jin Ikeda; Hiroyuki Matsuda; Takahiro Ueno; Masanori Abe; Kazuyoshi Okada; Masayoshi Soma; Koichi Matsumoto; Hiroshi Kawachi
Journal:  Stem Cell Res Ther       Date:  2015-04-16       Impact factor: 6.832

5.  Modulation of cyclins and p53 in mesangial cell proliferation and apoptosis during Habu nephritis.

Authors:  Yang Lu; Jun Wen; DaPeng Chen; LingLing Wu; QingGang Li; Yuansheng Xie; Di Wu; Xiaoluan Liu; XiangMei Chen
Journal:  Clin Exp Nephrol       Date:  2015-09-10       Impact factor: 2.801

6.  Dedifferentiated fat cells in polyglycolic acid-collagen nerve conduits promote rat facial nerve regeneration.

Authors:  Hiroshi Fujimaki; Hajime Matsumine; Hironobu Osaki; Yoshifumi Ueta; Wataru Kamei; Mari Shimizu; Kazuki Hashimoto; Kaori Fujii; Tomohiko Kazama; Taro Matsumoto; Yosuke Niimi; Mariko Miyata; Hiroyuki Sakurai
Journal:  Regen Ther       Date:  2019-09-12       Impact factor: 3.419

Review 7.  Mesenchymal stem cells as a therapeutic approach to glomerular diseases: benefits and risks.

Authors:  Uta Kunter; Song Rong; Marcus J Moeller; Jürgen Floege
Journal:  Kidney Int Suppl (2011)       Date:  2011-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.